Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma.

The Journal of pathology - 1 Mar 2014

Caffarel Maria M, Coleman Nicholas

Abstract excerpt

Cervical carcinoma is the second most common cause of cancer deaths in women worldwide. Treatments have not changed for decades and survival rates for advanced disease remain low. An exciting new molecular target for the treatment of cervical squamous cell carcinoma (SCC), and possibly for SCCs at other anatomical sites, is the oncostatin M receptor (OSMR). This cell surface cytokine receptor is commonly copy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Squamous Cell
Share to Chromosomes, Human, Pair 5

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Design

Share to Gene Amplification

Share to Molecular Targeted Therapy

Share to Up-Regulation

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 24659184
DOI: 10.1002/path.4305
PMCID: PMC4260121

Genes

OSMR
OSM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma.PMID 24659184Read ↗

Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro‐angiogenic phenotype and increased cell motility and invasivenessSemantic proximity Read ↗

Oncostatin M receptor overexpression promotes tumour progression in squamous cell carcinoma, via hypoxia signalling and multiple effects on the tumour microenvironmentSemantic proximity Read ↗

Gain and overexpression of the oncostatin M receptor occur frequently in cervical squamous cell carcinoma and are associated with adverse clinical outcomeSemantic proximity Read ↗

Activation of OSM-STAT3 Epigenetically Regulates Tumor-Promoting Transcriptional Programs in Cervical CancerSemantic proximity Read ↗

Stromal Oncostatin M axis promotes breast cancer progressionSemantic proximity Read ↗

ESM1/VEGFα/ERK signaling axis augments cell proliferation and tumor angiogenesis in human cervical squamous cell carcinomaSemantic proximity Read ↗

ESM1/VEGFα signaling pathway augments endothelial cell proliferation and tumor angiogenesis in human cervical squamous cell carcinomaSemantic proximity Read ↗

Integrated MicroRNA–mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast CancerSemantic proximity Read ↗

High expression of TMEM33 predicts poor prognosis and promotes cell proliferation in cervical cancerSemantic proximity Read ↗

SULF1 promotes malignancy potential of cervical cancer by activating VEGFR2/PI3K/AKT signaling pathwaySemantic proximity Read ↗

Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.Semantic proximity Read ↗

Association of oncostatin M receptor polymorphisms with clinical recurrence of ovarian cancer in the Chinese Han population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.